+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Healthcare Licensing - Country Trends: China Mid-Year Review

  • ID: 4604813
  • Report
  • July 2018
  • Region: Global, China
  • 142 pages
  • FinGlobe, Inc
1 of 2
This mid-year review report brings at one place all the news for licensing deals and negotiations that took place between healthcare companies of China and other countries worldwide during January 1, 2018 to June 30, 2018. The licensing trends and directions during this time period are also analyzed comprehensively.

Key Features:
  • 6 months’ China healthcare licensing news at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing news
  • 8+ variables reflecting different forms of transactions done
  • Licensing trends and directions summarized
The Report is useful to:
  • China and other countries’ healthcare companies planning to introduce products in each other’s markets
  • Companies active in R&D and seeking new market base
  • Healthcare company executives negotiating licensing deals between China and other countries worldwide
  • Investors analyzing varied kinds of transaction options for licensing deals
Key analysis provided: January-June 2018
  • Total number of licensing deals from China companies to other countries’ companies
  • Total number of licensing deals from other countries’ companies to China companies
  • Total number of companies/institutes involved in China licensing deals
  • Most licensing deals signed by companies of which sub-industry within healthcare sector
  • Most licensing deals signed by which market capitalization group’s companies
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the licensing deals between chinese and other countries’ companies
  • Number of domestic and worldwide licensing between chinese and other countries’ companies
  • Number of R&D and commercialization licensing between chinese and other countries’ companies
  • Number of licensing deals discontinued between chinese and other countries’ companies
Note: Product cover images may vary from those shown
2 of 2
Introduction

Research Design

Section 1: Healthcare inventions licensed by China to Other Countries
1.1 By China company name
1.2 By Other country company name
1.3 By Sub-industry
1.4 By Market capitalization groups
1.5 By Terms of payment
1.6 By Medical groups

Section 2: Healthcare inventions licensed by Other Countries to China
2.1 By Other country company name
2.2 By China company name
2.3 By Sub-industry
2.4 By Market capitalization groups
2.5 By Terms of payment
2.6 By Medical groups

Section 3: Healthcare inventions licensed within China

Section 4: Trends in China healthcare licensing deals
4.1 Healthcare sub-sector with most licensing deals
4.2 Market capitalization groups with most licensing deals
4.3 Healthcare companies most active in outbound and inbound licensing deals
4.4 Medical groups most active in licensing deals
4.5 Licensing payment arrangements most followed
4.6 Worldwide licensing vs domestic licensing
4.7 R&D licensing vs commercialization licensing
4.8 Licensing deals which discontinued

Section 5: Trends and directions

Appendices
Appendix 1 List of China-based companies/institutes covered in this report
Appendix 2 List of other countries’ companies/institutes covered in this report
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll